NDC 46014-0601

Emtriva

Emtricitabine

Emtriva is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Excella Gmbh. The primary component is Emtricitabine.

• Product ID: 46014-0601_1920b87b-ac14-4b51-ae82-9ccf51f1b00e
• NDC: 46014-0601
• Product Type: Human Prescription Drug
• Proprietary Name: Emtriva
• Generic Name: Emtricitabine
• Dosage Form: Capsule
• Route of Administration: ORAL
• Marketing Start Date: 2003-07-02
• Marketing Category: NDA / NDA
• Application Number: NDA021500
• Labeler Name: Excella GmbH
• Substance Name: EMTRICITABINE
• Active Ingredient Strength: 200 mg/1
• Pharm Classes: Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
• NDC Exclude Flag: E
• Listing Certified Through: 2018-12-31

Packaging

NDC 46014-0601-1

30 CAPSULE in 1 BOTTLE, PLASTIC (46014-0601-1)

• Marketing Start Date: 2003-07-02
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 46014-0601-1 [46014060101]

Emtriva CAPSULE

• Marketing Category: NDA
• Application Number: NDA021500
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2003-07-02
• Inactivation Date: 2020-01-31

Drug Details

Active Ingredients

Ingredient	Strength
EMTRICITABINE	200 mg/1

OpenFDA Data

• SPL SET ID: 946b680e-34e2-4789-8a9f-c00f851ad033
• Manufacturer:
  • Excella GmbH
• UNII:
  • G70B4ETF4S
• RxNorm Concept Unique ID - RxCUI:
  • 403875
  • 404587

Pharmacological Class

• Nucleoside Analog [EXT]
• Nucleoside Reverse Transcriptase Inhibitors [MoA]
• Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]

NDC Crossover Matching brand name "Emtriva" or generic name "Emtricitabine"

NDC	Brand Name	Generic Name
46014-0601	Emtriva	emtricitabine
53808-0801	Emtriva	emtricitabine
61958-0601	Emtriva	EMTRICITABINE
61958-0602	Emtriva	EMTRICITABINE
70518-1847	Emtriva	EMTRICITABINE
69097-642	emtricitabine	emtricitabine
70518-2906	emtricitabine	emtricitabine